Article | April 20, 2016

Staying On Track With A FDA Regulatory Submission When Manual Intervention Is Required

Staying On Track With A FDA Regulatory Submission When Manual Intervention Is Required

Managing large global trials involving tens of thousands of patients is only possible with the help of automated systems. Yet, even with the use of software to randomize patients and manage kit assignments, anomalies can crop up in the way that sites deal with patients and kits. From time to time, studies require manual intervention in the system records—a process that can jeopardize data quality if it is not handled and recorded properly.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader